Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190

Watchlist Manager
Zylox-Tonbridge Medical Technology Co Ltd Logo
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
Watchlist
Price: 15.38 HKD 1.72%
Market Cap: 5B HKD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one Zylox-Tonbridge Medical Technology Co Ltd stock under the Base Case scenario is 21.05 HKD. Compared to the current market price of 15.38 HKD, Zylox-Tonbridge Medical Technology Co Ltd is Undervalued by 27%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
21.05 HKD
Undervaluation 27%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

7
P/S
P/S
Price to Sales
7
vs History
76
vs Industry
21
Median 3Y
8
Median 5Y
7.2
Industry
2.3
Forward
5.8
More Details
181.6
P/E
P/E
Price to Earnings
181.6
vs History
4
vs Industry
Median 3Y
-21
Median 5Y
-26.5
Industry
22.7
Forward
45.3
More Details
21.1
P/OCF
P/OCF
Price to OCF
21.1
vs History
19
vs Industry
11
Median 3Y
-25.1
Median 5Y
-29.1
Industry
13.8
More Details
57.3
P/FCFE
P/FCFE
Price to FCFE
57.3
vs History
4
vs Industry
Median 3Y
-13.3
Median 5Y
-14.1
Industry
19.6
More Details
1.5
P/B
P/B
Price to Book Value
1.5
vs History
57
vs Industry
61
Median 3Y
1.1
Median 5Y
1.1
Industry
2.2
More Details
5.4
EV/S
EV/S
Enterprise Value to Sales
5.4
vs History
40
vs Industry
36
Median 3Y
3.5
Median 5Y
3.2
Industry
2.4
Forward
4.5
More Details
7.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
7.5
vs History
40
vs Industry
48
Median 3Y
4.9
Median 5Y
4.5
Industry
5
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
57
Median 3Y
-11.1
Median 5Y
-11.9
Industry
12
Forward
36.1
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
52
Median 3Y
-9.5
Median 5Y
-10.1
Industry
16.5
Forward
66.4
More Details
16.1
EV/OCF
EV/OCF
Enterprise Value to OCF
16.1
vs History
19
vs Industry
24
Median 3Y
-2.1
Median 5Y
-4.4
Industry
13.5
More Details
157.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
157.3
vs History
4
vs Industry
45
Median 3Y
-3.7
Median 5Y
-5.9
Industry
17
More Details
1.6
EV/IC
EV/IC
Enterprise Value to IC
1.6
vs History
61
vs Industry
57
Median 3Y
1.1
Median 5Y
1.1
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Zylox-Tonbridge Medical Technology Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
5B HKD 7 181.6 -167.9 -167.9
US
Abbott Laboratories
NYSE:ABT
220.3B USD 5.3 16.4 22 32.2
US
Intuitive Surgical Inc
NASDAQ:ISRG
181.1B USD 21.7 78 60.5 73.4
US
Boston Scientific Corp
NYSE:BSX
151.3B USD 9 81.6 37.3 52.6
US
Stryker Corp
NYSE:SYK
142.7B USD 6.3 47.7 24.7 29.8
IE
Medtronic PLC
NYSE:MDT
115.7B USD 3.5 27.2 14.4 20.4
US
Becton Dickinson and Co
NYSE:BDX
66.5B USD 3.2 38 15.8 28.5
DE
Siemens Healthineers AG
XETRA:SHL
57.8B EUR 2.5 29.1 16.6 23.6
US
Edwards Lifesciences Corp
NYSE:EW
42B USD 7.7 10.1 23.6 26.1
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
291B CNY 7.8 23.5 20.5 20.5
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
37.3B USD 1.9 18.7 13.1 16

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 241,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.